| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8222256 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 6 Pages |
Abstract
Hypofractionated PBT to the thorax delivered over 3 weeks was well tolerated even with significant doses to the lungs and mediastinal structures. Phase 2/3 trials are needed to compare the efficacy of this technique with standard treatment for locally advanced NSCLC.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Daniel R. MD, Michael PhD, Zhongxing MD, Caimiao PhD, Steven H. MD, PhD, Cameron MD, Tina BS, Ritsuko MD, James D. MD, Joe Y. MD, PhD,